Skip to Main Content

INFORMATION FOR

Kasia Lipska

MD, MHS, BS
Associate Professor of Medicine; Affiliated Faculty, Yale Institute for Global Health

Contact Information

Kasia Lipska, MD, MHS, BS

Mailing Address

  • Endocrinology

    Section of Endocrinology, Dept of Internal Medicine, Yale School of Medicine, PO Box 208020

    New Haven, CT 06520-8020

    United States

Research Summary

Dr. Lipska conducts diabetes outcomes research to help provide better information for patients and providers about the risks and benefits of various treatment options available for managing type 2 diabetes.

Specialized Terms: diabetes outcomes research; diabetes management of older adults; hypoglycemia; cardiovascular complications of diabetes; global health

Research Interests

Aging; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Endocrinology; Hypoglycemia; India; Insulin; Global Health; Drug Costs; Multiple Chronic Conditions

Selected Publications

  • U.S. PATTERNS OF DRUG UTILIZATION AND PRESCRIPTION FILLS FOR PROVEN CARDIOPROTECTIVE ANTI-HYPERGLYCEMIC AGENTSNargesi A, Clark C, Liu M, Chen L, Reddy A, Amodeo S, Oikonomou E, Suchard M, Lipska K, McGuire D, Lin Z, Inzucchi S, Krumholz H, Khera R. U.S. PATTERNS OF DRUG UTILIZATION AND PRESCRIPTION FILLS FOR PROVEN CARDIOPROTECTIVE ANTI-HYPERGLYCEMIC AGENTS Journal Of The American College Of Cardiology 2022, 79: 1446. DOI: 10.1016/s0735-1097(22)02437-8.
  • Abstract 13948: Patterns of Prescribing Sodium-Glucose Cotransporter-2 Inhibitors for Medicare Beneficiaries in the United StatesSangha V, Lipska K, Lin Z, Inzucchi S, McGuire D, Krumholz H, Khera R. Abstract 13948: Patterns of Prescribing Sodium-Glucose Cotransporter-2 Inhibitors for Medicare Beneficiaries in the United States Circulation 2021, 144: a13948-a13948. DOI: 10.1161/circ.144.suppl_1.13948.
  • 1014-P: The Impact of Baseline A1C and Admission Glucose on Mortality among Patients with Diabetes Hospitalized with COVID-19BRANCALE J, ATHONVARANGKUL D, SIMONOV M, ALAUSA J, SUBAIR L, HAJDUK A, KANG Y, ARORA T, WILSON F, JASTREBOFF A, LIPSKA K. 1014-P: The Impact of Baseline A1C and Admission Glucose on Mortality among Patients with Diabetes Hospitalized with COVID-19 Diabetes 2021, 70 DOI: 10.2337/db21-1014-p.
  • 49-LB: Navigating Barriers to Affording and Obtaining Diabetes TreatmentWILCOX A, KERANDI L, LIPSKA K, WEINZIMER S, NALLY L. 49-LB: Navigating Barriers to Affording and Obtaining Diabetes Treatment Diabetes 2021, 70 DOI: 10.2337/db21-49-lb.
  • 864-P: Treatment Burden and Quality of Life Conversations during Clinical Encounters: A Videographic AnalysisHAIDER S, EL KAWKGI O, CLARK J, BRESLIN M, BOEHMER K, MONTORI V, LIPSKA K. 864-P: Treatment Burden and Quality of Life Conversations during Clinical Encounters: A Videographic Analysis Diabetes 2021, 70 DOI: 10.2337/db21-864-p.
  • 882-P: QBSAFE: Pilot Study of an Intervention to Shift the Paradigm of Diabetes CareCLARK J, BOEHMER K, BRESLIN M, HAIDER S, PASCIAK W, GRAVHOLT D, SANCHEZ B, HARTASANCHEZ S, EL KAWKGI O, MONTORI V, LIPSKA K. 882-P: QBSAFE: Pilot Study of an Intervention to Shift the Paradigm of Diabetes Care Diabetes 2021, 70 DOI: 10.2337/db21-882-p.
  • Obesity Is Associated With Intensive Care Use and Duration of ICU Stay but Not Mortality Among 3246 Patients Hospitalized With COVID-19Kang Y, Brancale J, Athonvarangkul D, Alausa J, Subair L, Lipska K, Jastreboff A. Obesity Is Associated With Intensive Care Use and Duration of ICU Stay but Not Mortality Among 3246 Patients Hospitalized With COVID-19 Journal Of The Endocrine Society 2021, 5: a61-a62. PMCID: PMC8089233, DOI: 10.1210/jendso/bvab048.125.
  • CONTEMPORARY NATIONAL PATTERNS OF ELIGIBILITY AND UTILIZATION OF NOVEL CARDIOPROTECTIVE ANTI-HYPERGLYCEMIC AGENTS IN TYPE 2 DIABETESNargesi A, Jeyashanmugaraja G, Desai N, Lipska K, Krumholz H, Khera R. CONTEMPORARY NATIONAL PATTERNS OF ELIGIBILITY AND UTILIZATION OF NOVEL CARDIOPROTECTIVE ANTI-HYPERGLYCEMIC AGENTS IN TYPE 2 DIABETES Journal Of The American College Of Cardiology 2021, 77: 1535. DOI: 10.1016/s0735-1097(21)02893-x.
  • 1157-P: Out-of-Pocket and Health Plan Spending on Diabetes Drugs, 2006-2018LIPSKA K, MCCOY R, HOUTEN H, YAO X, ROSS J, ALTAN A, SHAH N. 1157-P: Out-of-Pocket and Health Plan Spending on Diabetes Drugs, 2006-2018 Diabetes 2020, 69 DOI: 10.2337/db20-1157-p.
  • 379-P: Glucagon Use by U.S. Adults with Type 1 and Type 2 DiabetesKAHN P, LIU S, MCCOY R, GABBAY R, LIPSKA K. 379-P: Glucagon Use by U.S. Adults with Type 1 and Type 2 Diabetes Diabetes 2020, 69 DOI: 10.2337/db20-379-p.
  • 380-P: Hypoglycemia among Nursing Home Residents with Diabetes Detected by Continuous Glucose Monitoring (CGM)LIPSKA K, DOYLE M, CENGIZ E, DROZDOWICZ B, GILL T, MURPHY T, INZUCCHI S. 380-P: Hypoglycemia among Nursing Home Residents with Diabetes Detected by Continuous Glucose Monitoring (CGM) Diabetes 2020, 69 DOI: 10.2337/db20-380-p.
  • Self-care practices and needs in patients with hypertension, diabetes, or both in rural Uganda: a mixed-methods studyTusubira A, Nalwadda C, Akiteng A, Armstrong-Hough M, Hsieh E, Ngaruiya C, Rabin T, Hawley N, Lipska K, Kalyesubula R, Ssinabulya I, Schwartz J. Self-care practices and needs in patients with hypertension, diabetes, or both in rural Uganda: a mixed-methods study The Lancet Global Health 2020, 8: s19. DOI: 10.1016/s2214-109x(20)30160-1.
  • SCREENING FOR NEWLY DIAGNOSED DIABETES IN YOUNG ADULTS HOSPITALIZED WITH ACUTE MYOCARDIAL INFARCTION-RESULTS FROM THE VIRGO (VARIATION IN RECOVERY ROLE OF GENDER ON OUTCOMES OF YOUNG ACUTE MYOCARDIAL INFARCTION PATIENTS) STUDYDing Q, Spatz E, Lipska K, Lin H, Spertus J, Dreyer R, Whittemore R, Funk M, Bueno H, Krumholz H. SCREENING FOR NEWLY DIAGNOSED DIABETES IN YOUNG ADULTS HOSPITALIZED WITH ACUTE MYOCARDIAL INFARCTION-RESULTS FROM THE VIRGO (VARIATION IN RECOVERY ROLE OF GENDER ON OUTCOMES OF YOUNG ACUTE MYOCARDIAL INFARCTION PATIENTS) STUDY Journal Of The American College Of Cardiology 2020, 75: 1918. DOI: 10.1016/s0735-1097(20)32545-6.
  • 379-P: Changes in Diabetes Management after a Hospital Visit for Severe HypoglycemiaVIJAYAKUMAR P, LIU S, KAHN P, MCCOY R, KARTER A, LIPSKA K. 379-P: Changes in Diabetes Management after a Hospital Visit for Severe Hypoglycemia Diabetes 2019, 68 DOI: 10.2337/db19-379-p.
  • 1249-P: Development and Validation of a Measure for Appropriateness of Glucose-Lowering TherapyMCCOY R, LIPSKA K, HOUTEN H, SHAH N. 1249-P: Development and Validation of a Measure for Appropriateness of Glucose-Lowering Therapy Diabetes 2019, 68 DOI: 10.2337/db19-1249-p.
  • 1607-P: Prevalence and Correlates of Potential Glycemic Overtreatment and Undertreatment among U.S. Adults with DiabetesMCCOY R, LIPSKA K, HOUTEN H, SHAH N. 1607-P: Prevalence and Correlates of Potential Glycemic Overtreatment and Undertreatment among U.S. Adults with Diabetes Diabetes 2019, 68 DOI: 10.2337/db19-1607-p.
  • Cost-Related Insulin Underuse Is Common and Associated with Poor Glycemic ControlHERKERT D, VIJAYAKUMAR P, LUO J, SCHWARTZ J, RABIN T, DEFILIPPO E, LIPSKA K. Cost-Related Insulin Underuse Is Common and Associated with Poor Glycemic Control Diabetes 2018, 67 DOI: 10.2337/db18-2-or.
  • Does Initiation of Basal Insulin Analogs in Patients with Type 2 Diabetes Mellitus Confer Advantages over Neutral Protamine Hagedorn (NPH) for Severe Hypoglycemia and Glycemic Control?LIPSKA K, PARKER M, MOFFET H, HUANG E, KARTER A. Does Initiation of Basal Insulin Analogs in Patients with Type 2 Diabetes Mellitus Confer Advantages over Neutral Protamine Hagedorn (NPH) for Severe Hypoglycemia and Glycemic Control? Diabetes 2018, 67 DOI: 10.2337/db18-1311-p.
  • High-Risk Medication Use to Achieve Tight Glycemic Control among U.S. Adults with Serious Chronic ConditionsMCCOY R, HOUTEN H, LIPSKA K, SHAH N. High-Risk Medication Use to Achieve Tight Glycemic Control among U.S. Adults with Serious Chronic Conditions Diabetes 2018, 67 DOI: 10.2337/db18-1652-p.
  • Hospitalization and Emergency Department Visits for Severe Hypoglycemia among U.S. Adults with Diabetes and Serious Comorbid ConditionsMCCOY R, VAN HOUTEN H, LIPSKA K, SHAH N. Hospitalization and Emergency Department Visits for Severe Hypoglycemia among U.S. Adults with Diabetes and Serious Comorbid Conditions Diabetes 2018, 67 DOI: 10.2337/db18-381-p.
  • Abstract 190: Use of Intensive Glycemic Management in Older Adults With Diabetes. An Analysis From the Diabetes Collaborative RegistryArnold S, Lipska K, Wang J, Seman L, Mehta S, Kosiborod M. Abstract 190: Use of Intensive Glycemic Management in Older Adults With Diabetes. An Analysis From the Diabetes Collaborative Registry Circulation Cardiovascular Quality And Outcomes 2018, 11 DOI: 10.1161/circoutcomes.11.suppl_1.190.
  • ADMISSION TYPES AMONG PATIENTS WITH HEART FAILURE CARED FOR BY ACCOUNTABLE CARE ORGANIZATIONS: VARIATION BY PERFORMANCE ON A MEASURE OF RISK STANDARDIZED ACUTE ADMISSION RATESBenchetrit L, Zimmerman C, Bao H, Dharmarajan K, Atlaf F, Herrin J, Lin Z, Krumholz H, Drye E, Lipska K, Spatz E. ADMISSION TYPES AMONG PATIENTS WITH HEART FAILURE CARED FOR BY ACCOUNTABLE CARE ORGANIZATIONS: VARIATION BY PERFORMANCE ON A MEASURE OF RISK STANDARDIZED ACUTE ADMISSION RATES Journal Of The American College Of Cardiology 2017, 69: 762. DOI: 10.1016/s0735-1097(17)34151-7.
  • ACUTE ADMISSION RATES FOR PATIENTS WITH HEART FAILURE CARED FOR BY ACCOUNTABLE CARE ORGANIZATIONSSpatz E, Lipska K, Dai Y, Altaf F, Joyce E, Montague J, Bao H, Sutton L, Parzynski C, Herrin J, Zhang V, Ross J, Lin Z, Bernheim S, Krumholz H, Drye E. ACUTE ADMISSION RATES FOR PATIENTS WITH HEART FAILURE CARED FOR BY ACCOUNTABLE CARE ORGANIZATIONS Journal Of The American College Of Cardiology 2015, 65: a782. DOI: 10.1016/s0735-1097(15)60782-3.
  • Abstract 11420: Long-Term Mortality, MACE, and Angina Among Patients With Diabetes and Myocardial InfarctionArnold S, Spertus J, McGuire D, Lipska K, Li Y, Xu Y, Stolker J, Goyal A, Kosiborod M. Abstract 11420: Long-Term Mortality, MACE, and Angina Among Patients With Diabetes and Myocardial Infarction Circulation 2014, 130 DOI: 10.1161/circ.130.suppl_2.11420.
  • Abstract 4: Recognition of Newly-Diagnosed Diabetes Mellitus During an Acute Myocardial InfarctionArnold S, Stolker J, Lipska K, Li Y, Spertus J, McGuire D, Inzucchi S, Goyal A, Maddox T, Lind M, Shore S, Kosiborod M. Abstract 4: Recognition of Newly-Diagnosed Diabetes Mellitus During an Acute Myocardial Infarction Circulation Cardiovascular Quality And Outcomes 2014, 7 DOI: 10.1161/circoutcomes.7.suppl_1.4.
  • Abstract 154: Type of Beta Blocker Use Among Patients with Versus without Diabetes after Myocardial InfarctionArnold S, McGuire D, Lipska K, Tang F, Spertus J, Goyal A, Gore M, Lanfear D, Maddox T, Kosiborod M. Abstract 154: Type of Beta Blocker Use Among Patients with Versus without Diabetes after Myocardial Infarction Circulation Cardiovascular Quality And Outcomes 2013, 6 DOI: 10.1161/circoutcomes.6.suppl_1.a154.
  • ASSOCIATION OF DIABETES MELLITUS WITH POST-MYOCARDIAL INFARCTION ANGINA: ANALYSIS OF THE TRIUMPH PROSPECTIVE COHORT STUDYArnold S, Spertus J, Lipska K, Tang F, Goyal A, McGuire D, Cresci S, Maddox T, Kosiborod M. ASSOCIATION OF DIABETES MELLITUS WITH POST-MYOCARDIAL INFARCTION ANGINA: ANALYSIS OF THE TRIUMPH PROSPECTIVE COHORT STUDY Journal Of The American College Of Cardiology 2013, 61: e1561. DOI: 10.1016/s0735-1097(13)61561-2.
  • TEMPORAL TRENDS IN THE MANAGEMENT OF SEVERE HYPERGLYCEMIA AMONG PATIENTS HOSPITALIZED WITH ACUTE MYOCARDIAL INFARCTIONVENKITACHALAM L, Riley K, Lipska K, Inzucchi S, Goyal A, Spertus J, Masoudi F, Jones P, Kosiborod M. TEMPORAL TRENDS IN THE MANAGEMENT OF SEVERE HYPERGLYCEMIA AMONG PATIENTS HOSPITALIZED WITH ACUTE MYOCARDIAL INFARCTION Journal Of The American College Of Cardiology 2010, 55: a143.e1339. DOI: 10.1016/s0735-1097(10)61340-x.
  • Cardiovascular risk-benefit ratio of thiazolidinedionesLipska K, Inzucchi S. Cardiovascular risk-benefit ratio of thiazolidinediones Current Cardiovascular Risk Reports 2008, 3: 42-50. DOI: 10.1007/s12170-009-0008-9.